Organogenesis Holdings
ORGO
104 hedge funds and large institutions have $167M invested in Organogenesis Holdings in 2023 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 35 increasing their positions, 37 reducing their positions, and 22 closing their positions.
451% more call options, than puts
Call options by funds: $601K | Put options by funds: $109K
0.54% more ownership
Funds ownership: 39.45% → 39.99% (+0.54%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
3% less capital invested
Capital invested by funds: $172M → $167M (-$4.6M)
5% less repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 37
8% less funds holding
Funds holding: 113 → 104 (-9)
36% less first-time investments, than exits
New positions opened: 14 | Existing positions closed: 22
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$19M |
| 2 |
SCM
Soleus Capital Management
Greenwich,
Connecticut
|
+$1.81M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.74M |
| 4 |
Norges Bank
Oslo,
Norway
|
+$1.53M |
| 5 |
Dimensional Fund Advisors
Austin,
Texas
|
+$1.4M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAMP
Polar Asset Management Partners
Toronto,
Ontario, Canada
|
-$4.12M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$3.95M |
| 3 |
Hotchkis & Wiley Capital Management
Los Angeles,
California
|
-$2.9M |
| 4 |
ECM
ExodusPoint Capital Management
New York
|
-$2.77M |
| 5 |
Millennium Management
New York
|
-$2.73M |
ORGO Hedge Fund Activity: Q3 2023 in Review
104 of the 6,301 institutional investors tracked by Wall St. Rank reported a position in Organogenesis Holdings (ORGO) for Q3 2023, worth a combined $167M — down 2.7% from $172M a quarter earlier.
Sellers outnumbered buyers: 22 funds closed out of ORGO and 14 opened new positions — a net loss of 8 holders — while 37 trimmed existing stakes and 35 added.
The largest buyer was Morgan Stanley, adding an estimated $19M. The largest seller was Polar Asset Management Partners, exiting entirely with an estimated $4.12M sold.
- 104 institutional investors held Organogenesis Holdings (ORGO) as of Q3 2023, down from 113 in Q2 2023.
- Funds reported $167M of Organogenesis Holdings stock for Q3 2023, down 2.7% quarter-over-quarter.
- 14 funds opened new Organogenesis Holdings positions in Q3 2023 and 22 closed out, a net change of -8 holders.
- The largest Organogenesis Holdings buyer in Q3 2023 was Morgan Stanley, an estimated $19M added.
- The largest Organogenesis Holdings seller in Q3 2023 was Polar Asset Management Partners, an estimated $4.12M sold.
Based on aggregated 13F filings for Q3 2023.